CrushSCI.com
287.9Average days
252Median days
109Fastest days
521Longest days
832025 publications

Paper Review Records

All Paper Review Records

25 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

227 days

Seamless Phase I– II Cancer Clinical Trials Using Kernel‐Based Covariate Similarity

Authors
Kana Makino; Natsumi Makigusa; Masahiro KojimaShow moreShow less
Affiliations
1. Department of Data Science for Business Innovation Chuo University Tokyo JapanShow moreShow less
Source PDF DOI Publisher page
109 days

A Cautionary Note on Regional Consistency Evaluation With Multiple Primary Endpoints in Multiregional Clinical Trials

Authors
Gosuke HommaShow moreShow less
Affiliations
1. Astellas Pharma Inc. Tokyo JapanShow moreShow less
Source PDF DOI Publisher page
241 days

Dose Optimization Design for Randomized Phase II Trials With Toxicity and Efficacy Endpoints

Authors
Ryuta Tabata; Tomohiro Ohigashi; Takashi SozuShow moreShow less
Affiliations
1. Department of Information and Computer Technology, Graduate School of Engineering Tokyo University of Science Tokyo Japan; 2. Department of Information and Computer Technology, Faculty of Engineering Tokyo University of Science Tokyo JapanShow moreShow less
Source PDF DOI Publisher page
213 days

Quantitative Dose Optimization for Gene Therapy Trials: Implications for Project Optimus and Early‐Phase Design

Authors
Kevin Roberts; Jeffrey Palmer; Jessica Volpe; Wei Zhong; Avery McIntoshShow moreShow less
Affiliations
1. Pfizer Inc. Cambridge Massachusetts USA; 2. Takeda Cambridge Massachusetts USA; 3. Pfizer Inc. Collegeville Pennsylvania USAShow moreShow less
Source PDF DOI Publisher page
265 days

A Fast, Flexible Simulation Framework for Bayesian Adaptive Designs—The R Package BATSS

Authors
Dominique‐Laurent Couturier; Rainer Puhr; Stephane Heritier; Thomas Jaki; Elizabeth G. RyanShow moreShow less
Affiliations
1. MRC Biostatistics Unit University of Cambridge Cambridge UK; 2. School of Public Health and Preventive Medicine Monash University Melbourne Victoria Australia; 3. Faculty of Informatics and Data Science University of Regensburg Regensburg GermanyShow moreShow less
Source PDF DOI Publisher page
203 days

Sample Size Reduction by Applying ML Based Causal Inference Methods

Authors
Ahrim Youn; Gang Han; Emma Gerard; Neeraj Poonia; Sergio Olmos; Bingzhi Zhang; Meehyung Cho; Andres HousemanShow moreShow less
Affiliations
1. Evidence Generation and Decision Science, Sanofi Morristown New Jersey USA; 2. Evidence Generation and Decision Science, Sanofi Gentilly France; 3. Evidence Generation and Decision Science, Sanofi Hyderabad India; 4. Evidence Generation and Decision Science, Sanofi Barcelona Spain; 5. Biostatistics and Modeling, Argenx Boston Massachusetts USAShow moreShow less
Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review62 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at [email protected]

Enter your email address so we can reply. Your details will remain private.